Back
Prothena Corporation plc PRTA · Insights
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and deve... Price8.775
Market Cap409.26 M
Float25.79 M
CountryIE
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro